Fecal transplants in twins with autism improved symptoms — and the gut microbiome shifted too

Key Findings

The Brain Chemical Imbalance That Cuts Across Depression, Bipolar, and Schizophrenia 🧠

• A review of the tryptophan-kynurenine pathway finds a consistent pattern: the balance between a neuroprotective metabolite and a neurotoxic one is disrupted across four major psychiatric conditions.
• Mood disorders tend to accumulate the damaging compound; schizophrenia skews toward too much of the protective one — suggesting the same pathway produces different problems depending on which direction it tips.

Gut Bacteria in Parkinson's Patients Change With the Drugs Used to Treat It 💊

• A study of 42 Parkinson's patients and 25 matched controls in Southern China found meaningful differences in gut microbiome composition — including lower levels of bacteria that produce beneficial short-chain fatty acids.
• The twist: anticholinergic and dopaminergic medications used to treat Parkinson's were themselves associated with shifts in those same bacterial populations, making it harder to untangle disease from treatment.

Stomach Problems Predict Lasting Depression in Older Adults Across Four Countries 📊

• Analyzing data from over 40,000 adults aged 60 and older across China, Europe, the US, and South Korea, researchers found that chronic gastrointestinal conditions were independently linked to a "stable high" depressive symptom trajectory over 4–6 years.
• Upper gastrointestinal disorders showed near-zero variation across all four countries — an unusually consistent signal that points toward a shared biological mechanism rather than cultural or healthcare differences.

An Edible Hydrogel Delivered Parkinson's Therapy Through the Gut in Mice 🔬

• Scientists built an oral hydrogel from a plant-derived polysaccharide that resists stomach acid, gels inside the gut, and stays put for 24 hours after a single dose in Parkinson's mouse models.
• The hydrogel shifted microbiome composition, reduced abnormal protein clumping in both the gut and brain, and improved motor function — all via the gut-brain axis, without direct brain delivery.

Vagus Nerve Stimulation May Reset the Gut Microbiome in Kids With Neurodevelopmental Disorders ⚡

• A review of preclinical and clinical evidence argues that non-invasive vagus nerve stimulation could stabilize gut microbiota by modulating the autonomic nervous system and reducing inflammation — potentially addressing a root driver of conditions like autism and ADHD.
• Current microbiome-targeted therapies like probiotics have shown inconsistent results; the review positions vagus nerve stimulation as a host-side lever that could make those interventions more durable.

Antidepressants Have Gut Mechanisms Nobody Talks About in Gastroenterology 💡

• SSRIs and SNRIs don't just raise serotonin in the brain — they block the same transporter in gut tissue, elevating intestinal serotonin levels and activating receptors that regulate motility, secretion, and mucosal inflammation.
• A review synthesizing evidence across inflammatory bowel disease and gut-brain interaction disorders argues these drugs may function as multimodal gut modulators, though adequately powered randomized trials in these populations are still missing.